Sep 19, 2022
Normally used as a glucose-lowering agent in the treatment of type 2 diabetes, SGLT2 inhibitors have been found to have beneficial effects in patients with heart failure and kidney disease. Jo Cheah finds out more from cardiologist John Atherton.
Sep 5, 2022
Justin Coleman chats to infectious diseases physician Emily Tucker about one of the more common presentations in primary care – sore throat.